Forlax and transipeg are equally effective in treating childhood constipation.
ID
Bron
Verkorte titel
Aandoening
1. Constipation;
2. fecal incontinence;
3. abdominal pain.
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Defecation frequency;<br>
2. Frequency of faecal incontinence episodes.
Achtergrond van het onderzoek
Children presenting at the outpatient clinics of the gastroenterology of the Emma Children's hospital will be randomised to either Forlax or Transipeg as a laxans therapy. The difference between the two agents in success will be evaluated at the end of the study.
Doel van het onderzoek
Forlax and transipeg are equally effective in treating childhood constipation.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
None, because the children would be treated by laxants anyway. For this reason we don't assusme treatment as an intervention.
Publiek
Department of paediatric gastroenterology
Postbus 22660
N. Bekkali
Amsterdam 1100 DD
The Netherlands
+31-205662906
Wetenschappelijk
Department of paediatric gastroenterology
Postbus 22660
N. Bekkali
Amsterdam 1100 DD
The Netherlands
+31-205662906
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Infants between 6 months and 15 years;
2. Defecation frequency < 3/week;
3. No oral laxatives for 2 weeks;
4. No PEG-laxatives for 2 months.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Metabolic disease;
2. functional non-retentive faecal incontinence;
3. mental retardation;
4. cerebral palsy;
5. anal anomalies;
6. Hirschsprung's disease.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL1065 |
| NTR-old | NTR1098 |
| Ander register | : Transipeg-Forlax studie |
| ISRCTN | ISRCTN wordt niet meer aangevraagd |